216 related articles for article (PubMed ID: 19787833)
1. Clonality and allelotype analyses of focal nodular hyperplasia compared with hepatocellular adenoma and carcinoma.
Cai YR; Gong L; Teng XY; Zhang HT; Wang CF; Wei GL; Guo L; Ding F; Liu ZH; Pan QJ; Su Q
World J Gastroenterol; 2009 Oct; 15(37):4695-708. PubMed ID: 19787833
[TBL] [Abstract][Full Text] [Related]
2. Use of X-chromosome inactivation pattern and laser microdissection to determine the clonal origin of focal nodular hyperplasia of the liver.
Gong L; Li YH; Su Q; Li G; Zhang WD; Zhang W
Pathology; 2009; 41(4):348-55. PubMed ID: 19404847
[TBL] [Abstract][Full Text] [Related]
3. Clonality of nodular lesions in liver cirrhosis and chromosomal abnormalities in monoclonal nodules of altered hepatocytes.
Gong L; Li YH; Su Q; Chu X; Zhang W
Histopathology; 2010 Apr; 56(5):589-99. PubMed ID: 20459569
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management.
Shanbhogue AK; Prasad SR; Takahashi N; Vikram R; Sahani DV
Radiology; 2011 Mar; 258(3):673-93. PubMed ID: 21339346
[TBL] [Abstract][Full Text] [Related]
5. Focal nodular hyperplasia-like nodules arising in the setting of hepatic vascular disorders with portosystemic shunting show β-catenin activation.
Umetsu SE; Joseph NM; Cho SJ; Morotti R; Deshpande V; Jain D; Kakar S
Hum Pathol; 2023 Dec; 142():20-26. PubMed ID: 37806391
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma.
Rebouissou S; Bioulac-Sage P; Zucman-Rossi J
J Hepatol; 2008 Jan; 48(1):163-70. PubMed ID: 17997499
[TBL] [Abstract][Full Text] [Related]
7. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver.
Bioulac-Sage P; Rebouissou S; Sa Cunha A; Jeannot E; Lepreux S; Blanc JF; Blanché H; Le Bail B; Saric J; Laurent-Puig P; Balabaud C; Zucman-Rossi J
Gastroenterology; 2005 May; 128(5):1211-8. PubMed ID: 15887105
[TBL] [Abstract][Full Text] [Related]
8. Clonality and TP53 mutation analysis of focal nodular hyperplasia of the liver.
Zheng S; Cummings OW; Saxena R; Zhang S; Wang M; Williamson SR; Cheng M; Lopez-Beltran A; Montironi R; Hodges KB; Cheng L
Am J Clin Pathol; 2010 Jul; 134(1):65-70. PubMed ID: 20551268
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical stains of proliferating cell nuclear antigen, insulin-like growth factor 2 and clusterin help distinguish malignant from benign liver nodular lesions.
Lai JP; Chen ZM; Lok T; Chan OT; Himmelfarb E; Zhai Q; Lin F; Wang HL
J Clin Pathol; 2014 Jun; 67(6):464-9. PubMed ID: 24407433
[TBL] [Abstract][Full Text] [Related]
10. Quantification of liver fat content in liver and primary liver lesions using triple-echo-gradient-echo MRI.
Nougaret S; Monsonis B; Molinari N; Riviere B; Piron L; Kassam Z; Cassinotto C; Guiu B
Eur Radiol; 2020 Sep; 30(9):4752-4761. PubMed ID: 32318848
[TBL] [Abstract][Full Text] [Related]
11. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia.
Sannier A; Cazejust J; Lequoy M; Cervera P; Scatton O; Rosmorduc O; Wendum D
Liver Int; 2016 Nov; 36(11):1668-1676. PubMed ID: 26969817
[TBL] [Abstract][Full Text] [Related]
12. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma.
Paradis V; Benzekri A; Dargère D; Bièche I; Laurendeau I; Vilgrain V; Belghiti J; Vidaud M; Degott C; Bedossa P
Gastroenterology; 2004 May; 126(5):1323-9. PubMed ID: 15131793
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA Expression in Focal Nodular Hyperplasia in Comparison with Cirrhosis and Hepatocellular Carcinoma.
Lendvai G; Szekerczés T; Gyöngyösi B; Schlachter K; Kontsek E; Pesti A; Patonai A; Werling K; Kovalszky I; Schaff Z; Kiss A
Pathol Oncol Res; 2019 Jul; 25(3):1103-1109. PubMed ID: 30411298
[TBL] [Abstract][Full Text] [Related]
14. Comparative genomic hybridization. Synchronous occurrence of focal nodular hyperplasia and hepatocellular carcinoma in the same liver is not based on common chromosomal aberrations.
Kellner U; Jacobsen A; Kellner A; Mantke R; Roessner A; Röcken C
Am J Clin Pathol; 2003 Feb; 119(2):265-71. PubMed ID: 12579998
[TBL] [Abstract][Full Text] [Related]
15. OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy.
Sciarra A; Schmidt S; Pellegrinelli A; Maggioni M; Dondossola D; Pasquier J; Cigala C; Tosi D; Halkic N; Bulfamante G; Viale G; Bosari S; Balabaud C; Bioulac-Sage P; Sempoux C
Liver Int; 2019 Jan; 39(1):158-167. PubMed ID: 30218633
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous occurrence of focal nodular hyperplasia and HNF1A-inactivated hepatocellular adenoma: a collision tumor simulating a composite FNH-HCA.
Shih A; Lauwers GY; Balabaud C; Bioulac-Sage P; Misdraji J
Am J Surg Pathol; 2015 Sep; 39(9):1296-300. PubMed ID: 26274031
[TBL] [Abstract][Full Text] [Related]
17. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
Kitao A; Matsui O; Yoneda N; Kita R; Kozaka K; Kobayashi S; Gabata T
AJR Am J Roentgenol; 2018 Aug; 211(2):347-357. PubMed ID: 29708786
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide microsatellite analysis of focal nodular hyperplasia: a strong tool for the differential diagnosis of non-neoplastic liver nodule from hepatocellular carcinoma.
Nakayama S; Kanbara Y; Nishimura T; Nishida N; Hanioka K; Morita M; Fujita M; Sakurai K; Hayashi Y
J Hepatobiliary Pancreat Surg; 2006; 13(5):416-20. PubMed ID: 17013716
[TBL] [Abstract][Full Text] [Related]
19. MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio.
Lebert P; Adens-Fauquembergue M; Azahaf M; Gnemmi V; Behal H; Luciani A; Ernst O
Eur Radiol; 2019 Nov; 29(11):5742-5751. PubMed ID: 30993437
[TBL] [Abstract][Full Text] [Related]
20. Allelotype analysis of hepatocellular carcinoma.
Piao Z; Park C; Park JH; Kim H
Int J Cancer; 1998 Jan; 75(1):29-33. PubMed ID: 9426686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
